Here are daily stock recommendations for intraday mock trading of NSE/BSE cash, futures, and options from Tower Talk.
Tower Talk provides recommendations every weekend for the week ahead. Here you can find their recommendations and we track their success rate too. So that you understand the risks involved in following them.
7 to 11 August 2017
|Stock and News||Call||CMP||TGT||Success/Fail|
|Tata Elexi reported much improved results for Q1. The company declared a dividend of Rs. 16/- per share and also bonus shares in the ratio of 1:1. The share is rumoured to cross the magical price of Rs. 2000/- in a short time.||Buy||1696||2000|
|Maruti Suzuki reported a net profit of 1556.4 Cr. for Q1. This company has huge expansion plans on hand and even at current prices, it does merit a buy.||Buy||7775||8552.5|
|Shriram Transport Finance net profits rose by around 20% to 448.68 Cr. The share is still a good buy considering rising volumes of Truck sales and growth of the logistics industry.||Buy||991||1090.1|
|Sonata Software received distinction of being named Microsoft ISV Development Centre. This collaboration will bring huge opportunities to its fold. This cash rich company must be added. BUY.||Buy||160||176|
|SBI has reduced interest rates on savings accounts deposits below one Cr. from 4% to 3.5%. This will decrease cost of funds and increase profitability. Positive for SBI.||Buy||305.8||336.38|
|Sona Koyo (auto ancillary giant making steering wheels primarily for Maruti and other four wheelers) is faring extremely well. Buy for a year.||Buy||114||125.4|
|Tech Mahindra beat market expectations by declaring a big jump in profits. The company expects the margins to be maintained during the rest of the year. Accumulate.||Buy||409||449.9|
|Birla Corporation is setting up a Greenfield cement plant in Mukutban, Maharshtra (a cement starved state) at a cost of around 2400 Cr. After this 4 million tonnes addition, the total capacity will increase to 19.5 million tonnes. Big positive.||Buy||960||1056|
|Shakti Pumps shares being acquired by foreign funds. They expect the company to prices to take a big leap. A good long term bet.||Buy||505||555.5|
BEL Q1 profits rose 247.24% to 125.32Cr., on a 99% increase in sales, primarily on back of better defence orders. The pace is likely to continue for the rest of the year.
|Escorts Ltd has reported a 34% rise in Agri machinery for Q1. The tractor division and the motor cycle divisions are performing well. Profitability may take a 50% jump and so will the prices.||Buy||670.25||737.275|
|India Bull Real Estate posted double profits for Q1. The affordable housing sector is in a bull cycle. A prudent investment may give decent returns.||Buy||248.1||272.91|
|South India Bank Q1 net profit climbed 18% at 110.52 Cr. A climb in CASA ratio and declining NPAs are indications of better times to come.||Buy||29.3||32.23|
|GSFC, a fertilizer major and prominent manufacturer of Caprolactum, a basic input to make tyres, has increased prices. A good buy at current prices.||Buy||136||149.6|
|A lot of action is being witnessed in Oil Marketing Companies. It would be prudent to add IOC the results of which were fairly good.||Buy||418||459.8|
|A distinct rise in volumes of Tube Investments of India is indicating that there is some news in the offing. This Murguppa group company is worth accumulating.||Buy||755.75||831.325|
|ACC is showing witnessing a slow and steady rise in volumes and price too. And the merger with Ambuja will also aid rise in valuations. A good buy even now.||Buy||1818.45||2000.295|
|Power Grid reported an 18% jump in revenues (7390 Cr) for Q12017, and a net profit of 2052 Cr. With huge project hand, this is one of the best long term investment idea.||Buy||224||246.4|
|REC and PFC are both going to announce their Q1 results this week. There is practically no place to go down. Any good news on pending NPA issues may fuel a rally. BUY.||Buy||174.25||191.675|
|REC and PFC are both going to announce their Q1 results this week. There is practically no place to go down. Any good news on pending NPA issues may fuel a rally. BUY.||Buy||128.15||140.965|
|In spite of minor observations from USFDA, Biocon is still a good buy, especially after the recent correction. Buy for a short term target of Rs. 400/-.||Buy||356.65||400|
The information on this web-page is NOT any recommendation on buy and sell of stocks and/or derivatives. The information on this web-page is just for education and entertainment purpose. We do not claim that the information on this web-page is accurate. Sharesume or anyone from our team is not responsible for the inaccuracy of the information. Sharesume or anyone from our team is not responsible for any profits or loss that you make.